Mimedx (MDXG) Non-Current Debt (2011 - 2026)
Mimedx recorded quarterly Non-Current Debt of $16.1 million in Q1 2026, down 2.27% quarter-over-quarter from $16.5 million in Q4 2025, and down 8.21% year-over-year from $17.5 million in Q1 2025.
Mimedx's Non-Current Debt history runs 10 years deep, the most recent figure standing at $16.1 million for Q1 2026.
- In Q1 2026, Non-Current Debt fell 8.21% year-over-year to $16.1 million; the TTM figure through Mar 2026 stood at $16.1 million (down 8.21% YoY), while the FY2025 annual figure was $16.5 million, down 7.64% from the prior year.
- Non-Current Debt came in at $16.1 million for Q1 2026 at Mimedx, down from $16.5 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $49.0 million in Q3 2023 to a low of $16.1 million in Q1 2026.
- A 5-year average of $32.1 million and a median of $18.5 million in 2024 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt gained 1.01% in 2023 and slumped 63.2% in 2024, its largest moves.
- Mimedx's Non-Current Debt stood at $48.6 million in 2022, then dropped by 1.02% to $48.1 million in 2023, then slumped by 62.93% to $17.8 million in 2024, then dropped by 7.64% to $16.5 million in 2025, then slipped by 2.27% to $16.1 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $16.1 million, $16.5 million, and $16.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 105.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 16.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.09 Mn |
| Mar 31, 2026 | 16.09 Mn |
| Dec 31, 2025 | 16.47 Mn |
| Dec 31, 2025 | 16.47 Mn |
| Sep 30, 2025 | 16.84 Mn |
| Sep 30, 2025 | 16.84 Mn |
| Jun 30, 2025 | 17.21 Mn |
| Jun 30, 2025 | 17.21 Mn |
| Mar 31, 2025 | 17.53 Mn |
| Mar 31, 2025 | 17.53 Mn |
| Dec 31, 2024 | 17.83 Mn |
| Dec 31, 2024 | 17.83 Mn |
| Sep 30, 2024 | 18.02 Mn |
| Sep 30, 2024 | 18.02 Mn |
| Jun 30, 2024 | 18.25 Mn |
| Jun 30, 2024 | 18.25 Mn |
| Mar 31, 2024 | 18.45 Mn |
| Mar 31, 2024 | 18.45 Mn |
| Dec 31, 2023 | 48.10 Mn |
| Dec 31, 2023 | 48.10 Mn |
| Sep 30, 2023 | 48.97 Mn |
| Sep 30, 2023 | 48.97 Mn |
| Jun 30, 2023 | 48.84 Mn |
| Jun 30, 2023 | 48.84 Mn |
| Mar 31, 2023 | 48.71 Mn |
| Mar 31, 2023 | 48.71 Mn |
| Dec 31, 2022 | 48.59 Mn |
| Dec 31, 2022 | 48.59 Mn |
| Sep 30, 2022 | 48.48 Mn |
| Sep 30, 2022 | 48.48 Mn |
| Jun 30, 2022 | 48.36 Mn |
| Jun 30, 2022 | 48.36 Mn |
| Mar 31, 2022 | 48.24 Mn |
| Mar 31, 2022 | 48.24 Mn |
| Dec 31, 2021 | 48.13 Mn |
| Dec 31, 2021 | 48.13 Mn |
| Sep 30, 2021 | 48.02 Mn |
| Sep 30, 2021 | 48.02 Mn |
| Jun 30, 2021 | 47.91 Mn |
| Jun 30, 2021 | 47.91 Mn |
| Mar 31, 2021 | 47.80 Mn |
| Mar 31, 2021 | 47.80 Mn |
| Dec 31, 2020 | 47.70 Mn |
| Dec 31, 2020 | 47.70 Mn |
| Sep 30, 2020 | 47.63 Mn |
| Sep 30, 2020 | 47.63 Mn |
| Jun 30, 2020 | 61.47 Mn |
| Jun 30, 2020 | 61.47 Mn |
| Mar 31, 2020 | 61.64 Mn |
| Mar 31, 2020 | 61.64 Mn |
| Dec 31, 2019 | 61.91 Mn |
| Dec 31, 2019 | 61.91 Mn |
| Sep 30, 2019 | 62.17 Mn |
| Sep 30, 2019 | 62.17 Mn |
| Jun 30, 2019 | 63.07 Mn |
| Jun 30, 2019 | 63.07 Mn |
| Sep 30, 2012 | 1.17 Mn |
| Sep 30, 2012 | 1.17 Mn |
| Jun 30, 2012 | 976,238.00 |
| Jun 30, 2012 | 976,238.00 |
| Mar 31, 2012 | 809,152.00 |
| Mar 31, 2012 | 809,152.00 |
| Dec 31, 2011 | 1.30 Mn |
| Dec 31, 2011 | 1.30 Mn |
| Sep 30, 2011 | 1.27 Mn |
| Sep 30, 2011 | 1.27 Mn |
| Jun 30, 2011 | 7,704.00 |
| Jun 30, 2011 | 7,704.00 |